BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15024441)

  • 1. Life-threatenting ceftriaxone-induced immune hemolytic anemia in a child with Crohn's disease.
    Mattis LE; Saavedra JM; Shan H; Shirey RS; Powell E; Oliva-Hemker MM
    Clin Pediatr (Phila); 2004 Mar; 43(2):175-8. PubMed ID: 15024441
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion med illustrated: Ceftriaxone-induced acute hemolytic anemia.
    Tobian AA; Shirey RS; Savage WJ
    Transfusion; 2010 Aug; 50(8):1647-8. PubMed ID: 20931689
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.
    Tasch J; Gonzalez-Zayaz P
    Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced immune hemolytic anemia.
    Garratty G
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):98-101. PubMed ID: 20386530
    [No Abstract]   [Full Text] [Related]  

  • 9. A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2003 Nov; 43(11):1640-1. PubMed ID: 14617328
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
    Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
    Perm J; 2020; 24():. PubMed ID: 31905339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
    Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone-related hemolysis and acute renal failure.
    Demirkaya E; Atay AA; Musabak U; Sengul A; Gok F
    Pediatr Nephrol; 2006 May; 21(5):733-6. PubMed ID: 16491410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure].
    Mulkens CE; van Lochem EG; Folman CC; van der Spek E; van Leeuwen HJ
    Ned Tijdschr Geneeskd; 2015; 159():A8054. PubMed ID: 25714764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic anemia from ceftriaxone in an elderly patient: a case report.
    Imam SN; Wright K; Bhoopalam N; Choudhury A
    J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant.
    Wang Y; Pan T; Ma FR; Wang JJ; Zhang K; Pan WW; Zhang JH; Yi ZM; Ying YQ
    Chin Med J (Engl); 2019 Jan; 132(1):100-102. PubMed ID: 30628967
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.